Mentolift Plus 0.25 mg/50 mg Tablet
Prescription Required
Introduction of Mentolift Plus Tablet
Mentolift Plus 0.25 mg/50 mg Tablet is a combination medicine used to treat schizophrenia. It helps to decrease the abnormal and excessive activity of the nerve cells and calm the brain. It also works by modulating the action of certain chemical messengers in the brain that affect thoughts.
Mentolift Plus 0.25 mg/50 mg Tablet is a combination of benzodiazepines and atypical antipsychotics.
Mentolift Plus 0.25 mg/50 mg Tablet is a combination of benzodiazepines and atypical antipsychotics.
Uses of Mentolift Plus Tablet
Benefits of Mentolift Plus Tablet
In Schizophrenia
Schizophrenia is a mental disorder in which a person’s thinking ability, feelings and behavior become abnormal. Mentolift Plus 0.25 mg/50 mg Tablet helps restore the chemical imbalances in the brain that are responsible for such changes. It improves thoughts, behavior and enhances the quality of life.
Side effects of Mentolift Plus Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mentolift Plus
- Weight gain
- Confusion
- Sleepiness
- Memory impairment
- Dizziness
- Tiredness
- Restlessness
- Tremors
- Uncoordinated body movements
- Muscle stiffness
- Dryness in mouth
- Constipation
- Depression
How to use Mentolift Plus Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mentolift Plus 0.25 mg/50 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Mentolift Plus 0.25 mg/50 mg Tablet.
Pregnancy
CONSULT YOUR DOCTOR
Mentolift Plus 0.25 mg/50 mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Mentolift Plus 0.25 mg/50 mg Tablet during breastfeeding is not available. Please consult your doctor.
Driving
UNSAFE
Mentolift Plus 0.25 mg/50 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
SAFE IF PRESCRIBED
Mentolift Plus 0.25 mg/50 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Mentolift Plus 0.25 mg/50 mg Tablet may not be needed in these patients. Please consult your doctor.
Liver
CAUTION
Mentolift Plus 0.25 mg/50 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Mentolift Plus 0.25 mg/50 mg Tablet may be needed. Please consult your doctor.
What if you forget to take Mentolift Plus Tablet?
If you miss a dose of Mentolift Plus 0.25 mg/50 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
Mentolift Plus Tablet
- Mentolift Plus 0.25 mg/50 mg Tablet is used for the treatment of schizophrenia.
- Inform your doctor if you have severe heart disease, Parkinsons disease, diabetes before starting your treatment.
- Inform your doctor if you have a history of stroke, blood clots or if you are above 65 years of age.
- Before taking Mentolift Plus 0.25 mg/50 mg Tablet, tell your doctor if you have experienced fits convulsions) either recently or in the past.
- If you feel light-headed, dizzy, or faint when getting out of bed or standing up, get up slowly.
Fact Box
Habit Forming
Yes
Therapeutic Class
NEURO CNS
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- MedIndia. Alprazolam. [Accessed 22 Apr. 2019] (online) Available from:
- Sertaline.New York, New York: Pfizer; [revised May 2014]. [Accessed 22 Apr. 2019] (online) Available from:
Marketer details
Name: Symbiotic Drugs
Address: 35, Baddi, Solan - 173205, Export Promostion Industrial Park, Jharmajri
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present